nach oben

European Spine Journal

Erschienen in:

01.08.2006 | Review

Molecular therapy of the intervertebral disc

verfasst von: S. Tim Yoon, Nilpesh M. Patel

Erschienen in: European Spine Journal | Sonderheft 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Disc degeneration is the loss of the normal nucleus pulposus disc matrix to a more fibrotic and less cartilaginous structure. This change in disc micro-anatomy can be associated with pain and deformity, however, prevention and treatment options of disc degeneration are currently limited. Much research is going on to understand intervertebral discs at a molecular/ cellular level in hopes of creating clinically applicable options for treating disc degeneration. This review article will give insight into the current and developing status of treating intervertebral disc degeneration from a molecular standpoint.

Deyo RA, Tsui-Wu YJ (1987) Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 12:264–268PubMedCrossRef

Pritzker KP (1977) Aging and degeneration in the lumbar intervertebral disc. Orthop Clin North Am 8:66–77PubMed

Shvartzman L, Weingarten E, Sherry H, Levin S, Persaud A (1992) Cost-effectiveness analysis of extended conservative therapy versus surgical intervention in the management of herniated lumbar intervertebral disc. Spine 17:176–182PubMedCrossRef

Buckwalter JA, Einhorn TA, Simon SR (eds) (2000) Orthopedic basic science: biology and biomechanics of the musculoskeletal system, 2nd edn. American Academy of Orthopedic Surgeons, Rosemont, pp548–555

Lipson SJ, Muir H (1981) 1980 Volvo award in basic science: proteoglycans in experimental intervertebral disc degeneration. Spine 6:194–210PubMedCrossRef

Pearce RH, Grimmer BJ, Adams ME (1987) Degeneration and the chemical composition of the human lumbar intervertebral disc. J Orthop Res 5:198–205PubMedCrossRef

Henry SP, Takanosu M, Boyd TC, Mayne PM, Eberspaecher H, Zhou W, de Crombrugghe B, Hook M, Mayne R (2001) Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family (Epub 2001 Jan 10). J Biol Chem 276(15):12212–12221PubMedCrossRef

Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D (2001) Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 276(15):12201–12211PubMedCrossRef

Lorenzo P, Bayliss MT, Heinegard D (1998) A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 273(36):23463–23468PubMedCrossRef

10.

Boos N, Weissbachs S, Rohrbach H, et al. (2002) Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo award. Spine 27:2631–2644PubMedCrossRef

11.

Guiot BH, Fessler RG (2000) Molecular biology of degenerative disc disease. Neurosurgery 47(5):1034–1040PubMedCrossRef

12.

Roughley (2004) Parameters that influence change in nucleus pulposus composition. Spine 29(23):2691–2699PubMedCrossRef

13.

Liu J, Roughley PJ, Mort JS (1991) Identification of human intervertebral disc stromelysin and its involvement in matrix degradation. J Orthop Res 9:568–575PubMedCrossRef

14.

Seguin CA, Pilliar RM, Roughley PJ, Kandel RA (2005) Tumor necrosis factor [alpha] modulates matrix production and catabolism in nucleus pulposus tissue. Spine 30(17):1940–1948PubMedCrossRef

15.

Anderson DG, Li X, Balian G (2005) A fibronectin fragment alters the metabolism by rabbit intervertebral disc cells in vitro. Spine 30(11):1242–1246PubMedCrossRef

16.

Kang JD, Stefanovic-Racic M, McIntyre LA, Georgescu HI, Evans CH (1997) Toward a biochemical understanding of human intervertebral disc degeneration and herniation: contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 22:1065–1073PubMedCrossRef

17.

Takegami K, Thonar EJ, An HS, Kamada H, Masuda K (2002) Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine 27(12):1318–1325PubMedCrossRef

18.

Sakai D, Mochida J, Yamamoto Y, et al. (2003) Transplantation of mesenchymal stem cells embedded in atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials 24(20):3531–3541PubMedCrossRef

19.

Watanabe K, Mochida J, Nomura T, Okuma M, Sakabe K, Seiki K (2003) Effect of reinsertion of activated nucleus pulposus on disc degeneration: an experimental study on various types of collagen in degenerative discs. Connect Tissue Res 44(2):104–108PubMedCrossRef

20.

Brisby H, Tao H, Ma DD, Diwan AD (2004) Cell therapy for disc degeneration—potentials and pitfalls. Orthop Clin North Am 35(1):85–93PubMedCrossRef

21.

Gruber HE, Hanley EN Jr (2003) Biologic strategies for the therapy of intervertebral disc degeneration. Expert Opin Biol Ther 3(8):1209–1214PubMedCrossRef

22.

Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M (2002) A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J 11(Suppl 2):S215–S220PubMed

23.

Sato M, Asazuma T, Ishihara M, et al. (2003) An experimental study of the regeneration of the intervertebral disc with an allograft of cultured annulus fibrosus cells using a tissue-engineering method. Spine 28(6):548–553PubMedCrossRef

24.

Luk KD, Ruan DK, Chow DH, Leong JC (1997) Intervertebral disc autografting in a bipedal animal model. Clin Orthop Relat Res 337:13–26PubMedCrossRef

25.

Luk KD, Ruan DK, Lu DS, Fei ZQ (2003) Fresh frozen intervertebral disc allografting in a bipedal animal model. Spine 28(9):864–869PubMedCrossRef

26.

Pfeiffer M, Boudriot U, Pfeiffer D, Ishaque N, Goetz W, Wilke A (2003) Intradiscal application of hyaluronic acid in the non-human primate lumbar spine: radiological results. Eur Spine J 12(1):76–83PubMed

27.

Roberts S, Caterson B, Menage J et al (2000) Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 25:3005–3013:491–495

28.

Takahashi H, Suguro T, Okazima Y et al (1996) Inflammatory cytokines in the herniated disc of the lumbar spine. Spine 21:218–224PubMedCrossRef

29.

Fujita K, Nakagawa T, Hirabayashi K et al (1993) Neutral proteinases in human intervertebral disc: role in degeneration and probable origin. Spine 18:1766–1773PubMedCrossRef

30.

Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274(31):21491–21494PubMedCrossRef

31.

Wallach CJ, Sobajima S, Watanabe Y et al (2003) Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 28(20):2331–2337PubMedCrossRef

32.

Okuma M, An HS, Nakagawa K, Akeda K, Muehleman C, Masuda K (2005) Oral administration of esculetin prodrug inhibits intervertebral disc degeneration in the rabbit annular needle puncture model. Orthopaedic research society meeting, p 370

33.

Muller-Ladner U, Roberts CR, Franklin BN et al (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158(7):3492–3498PubMed

34.

Bandara G, Mueller GM, Galea-Lauri J et al (1993) Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90(22):10764–10768PubMedCrossRef

35.

Olmarker K, Rydevik B (2001) Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 26(8):863–869PubMedCrossRef

36.

Masuda K, Oegema TR Jr, An HS (2004) Growth factors and treatment of intervertebral disc degeneration. Spine 29(23):2757–2769PubMedCrossRef

37.

Thompson JP, Oegema TR Jr, Bradford DS (1991) Stimulation of mature canine intervertebral disc by growth factors. Spine 16(3):253–260PubMedCrossRef

38.

Walsh AJ, Bradford DS, Lotz JC (2004) In vivo growth factor treatment of degenerated intervertebral discs. Spine 29(2):156–163PubMedCrossRef

39.

Okuda S, Myoui A, Ariga K, Nakase T, Yonenobu K, Yoshikawa H (2001) Mechanisms of age-related decline in insulin-like growth factor-I dependent proteoglycan synthesis in rat intervertebral disc cells. Spine 26(22):2421–2426PubMedCrossRef

40.

Gruber HE, Norton HJ, Hanley EN Jr (2000) Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine 25(17):2153–2157PubMedCrossRef

41.

Matsunaga S, Nagano S, Onishi T, Morimoto N, Suzuki S, Komiya S (2003) Age-related changes in expression of transforming growth factor-beta and receptors in cells of intervertebral discs. J Neurosurg Spine 98(1):63–67CrossRef

42.

Takae R, Matsunaga S, Origuchi N et al (1999) Immunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral disc. Spine 24(14):1397–1401PubMedCrossRef

43.

Nishida K, Kang JD, Gilbertson LG et al (1999) Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 24(23):2419–2425PubMedCrossRef

44.

Yung LJ, Hall R, Pelinkovic D et al (2001) New use of a three-dimensional pellet culture system for human intervertebral disc cells: initial characterization and potential use for tissue engineering. Spine 26(21):2316–2322CrossRef

45.

Tan Y, Hu Y, Tan J (2003) Extracellular matrix synthesis and ultrastructural changes of degenerative disc cells transfected by Ad/CMV-hTGF-beta 1. Chin Med J (Engl) 116(9):1399–1403

46.

Yoon ST, Kim K, Li J et al (2003) The effect of bone morphogenetic protein-2 on rat interveretebral disc cells in vitro. Spine 28(16):1773–1780CrossRef

47.

Kim DJ, Moon SH, Kim H et al (2003) Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 28(24):2679–2684PubMedCrossRef

48.

Ahn S-H, Teng P-N, Niyibizi C et al (2002) The effects of BMP-12 and BMP-2 on proteoglycan and collagen synthesis in nucleus pulposus cells from human degenerated discs. ISSLS 29th annual meeting proceeding, p 49

49.

Masuda K, Takegami K, An H et al (2003) Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J Orthop Res 21(5):922–930PubMedCrossRef

50.

Zhang Y, An HS, Song S et al (2004) Growth factor osteogenic protein-1: differing effects on cells from three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil 83(7):515–521PubMedCrossRef

51.

An HS, Takegami K, Kamada H et al (2005) Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine 30(1):25–31PubMed

52.

Masuda K, Aota Y, Muehleman C et al (2005) A novel rabbit model of mild, reproducible disc degeneration by an annulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine 30(1):5–14PubMed

53.

Chang SC, Hoang B, Thomas JT et al (1994) Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269(45):28227–28234PubMed

54.

Li J, Kim KS, Park JS, Elmer WA, Hutton WC, Yoon ST (2003) BMP-2 and CDMP-2: stimulation of chondrocyte production of proteoglycan. J Orthop Sci 8(6):829–835PubMedCrossRef

55.

Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A(8):1544–1552. Erratum in: J Bone Joint Surg Am (2004) 86-A(1):141

56.

Mehta V, Kang Q, Luo J, He TC, Haydon RC, Mass DP (2005) Characterization of adenovirus-mediated gene transfer in rabbit flexor tendons. J Hand Surg [Am] 30(1):136–141CrossRef

57.

Helm GA, Li JZ, Alden TD, Hudson SB, Beres EJ, Cunningham M, Mikkelsen MM, Pittman DD, Kerns KM, Kallmes DF (2001) A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy. J Neurosurg 95(2):298–307PubMed

58.

Wang H, Kroeber M, Hanke M et al (2004) Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells. J Mol Med 82(2):126–134PubMedCrossRef

59.

Mwale F, Demers CN, Petit A et al (2003) A synthetic peptide of link protein stimulates the biosynthesis of collagens II, IX and proteoglycan by cells of the intervertebral disc. J Cell Biochem 88(6):1202–1213PubMedCrossRef

60.

Yoon ST, Park JS, Kim KS et al (2004) ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 29(23):2603–2611PubMedCrossRef

61.

Israel DI, Nove J, Kerns KM et al (1996) Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13(3–4):291–300PubMedCrossRef

62.

Nohe A, Keating E, Knaus P, Petersen NO (2004) Signal transduction of bone morphogenetic protein receptors. Cell Signal 16(3):291–299PubMedCrossRef

63.

Hatakeyama Y, Nguyen J, Wang X, Nuckolls GH, Shum L (2003) Smad signaling in mesenchymal and chondroprogenitor cells. J Bone Joint Surg Am 85-A(Suppl 3):13–18PubMed

64.

Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, Hawkins RE (2004) Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng 10(3–4):575–584PubMedCrossRef

65.

Aigner T, Gebhard PM, Schmid E, Bau B, Harley V, Poschl E (2003) SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 22(4):363–372PubMedCrossRef

66.

Paul R, Haydon RC, Cheng H et al (2003) Potential use of sox9 gene therapy for intervertebral degenerative disc disease. Spine 28(8):755–763PubMedCrossRef

Titel: Molecular therapy of the intervertebral disc
verfasst von: S. Tim Yoon
Nilpesh M. Patel
Publikationsdatum: 01.08.2006
Verlag: Springer-Verlag
Erschienen in: European Spine Journal / Ausgabe Sonderheft 3/2006
Print ISSN: 0940-6719
Elektronische ISSN: 1432-0932
DOI: https://doi.org/10.1007/s00586-006-0155-3

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 3/2006

Osmoviscoelastic finite element model of the intervertebral disc

Prevention of disc degeneration with growth factors

Injectable biomaterials and vertebral endplate treatment for repair and regeneration of the intervertebral disc

Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction

Genetics of disc degeneration